Nitrotyrosine is widely used as a marker of post-translational modification by the
nitric oxide ((.)NO,
nitrogen monoxide)-derived
oxidant peroxynitrite (ONOO(-)). However, since the discovery that
myeloperoxidase (MPO) and
eosinophil peroxidase (EPO) can generate
nitrotyrosine via oxidation of
nitrite (NO(2)(-)), several questions have arisen. First, the relative contribution of
peroxidases to
nitrotyrosine formation in vivo is unknown. Further, although evidence suggests that the one-electron oxidation product,
nitrogen dioxide ((*)NO(2)), is the primary species formed, neither a direct demonstration that
peroxidases form this gas nor studies designed to test for the possible concomitant formation of the two-electron oxidation product, ONOO(-), have been reported. Using multiple distinct models of acute
inflammation with EPO- and MPO-knockout mice, we now demonstrate that leukocyte
peroxidases participate in
nitrotyrosine formation in vivo. In some models, MPO and EPO played a dominant role, accounting for the majority of
nitrotyrosine formed. However, in other leukocyte-rich acute inflammatory models, no contribution for either MPO or EPO to
nitrotyrosine formation could be demonstrated. Head-space gas analysis of
helium-swept reaction mixtures provides direct evidence that leukocyte
peroxidases catalytically generate (*)NO(2) formation using H(2)O(2) and NO(2)(-) as substrates. However, formation of an additional
oxidant was suggested since both
enzymes promote NO(2)(-)-dependent hydroxylation of targets under acidic conditions, a chemical reactivity shared with ONOO(-) but not (*)NO(2). Collectively, our results demonstrate that: 1) MPO and EPO contribute to
tyrosine nitration in vivo; 2) the major
reactive nitrogen species formed by leukocyte
peroxidase-catalyzed oxidation of NO(2)(-) is the one-electron oxidation product, (*)NO(2); 3) as a minor reaction,
peroxidases may also catalyze the two-electron oxidation of NO(2)(-), producing a ONOO(-)-like product. We speculate that the latter reaction generates a labile Fe-ONOO complex, which may be released following protonation under acidic conditions such as might exist at sites of
inflammation.